Sweden Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Sweden Cardiovascular Devices Market is Segmented by Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical). The Report Offers the Value (in USD) for the Above Segments.

Sweden Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Sweden Cardiovascular Devices Market Size

View Global Report
Sweden Cardiovascular Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 0.34 Billion
Market Size (2030) USD 0.42 Billion
CAGR (2025 - 2030) 4.20 %

Major Players

Sweden Cardiovascular Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Sweden Cardiovascular Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Sweden Cardiovascular Devices Market Analysis

The Sweden Cardiovascular Devices Market size is estimated at USD 0.34 billion in 2025, and is expected to reach USD 0.42 billion by 2030, at a CAGR of 4.2% during the forecast period (2025-2030).

Factors such as rapid technological advancements, the increasing burden of CVD, and increased preference for minimally invasive procedures are projected to drive the demand for cardiovascular devices in Sweden, driving the market growth.

Cardiovascular disease (CVD) is Sweden's leading cause of healthcare burden. The prevalence and incidence of the disease are increasing with time. According to the article published by PubMed in March 2022, when the research was conducted in primary healthcare centers in southern Sweden, the overall prevalence of heart failure (HF) was 2.06%. 

The source also stated that age and the degree of multimorbidity increase the prevalence of HF, and 99.07% of the patients with HF were associated with multimorbidity. Thus, such a high burden and persistent risk of CVD among the target population in Sweden is expected to demand cardiology medical devices for treatment and diagnosis, thereby driving the market growth.

The increasing mergers and acquisitions of products and services and product innovations fuel market growth. For instance, in June 2022, Coala-Life Group AB, a Swedish medical technology company, agreed to acquire 100% of the shares in Vitrics Management Group Inc. for a purchase price of USD 4.5 million on a cash and debt-free basis. Vitrics' platform and customer base will be able to be scaled up through Coala's national sales force, enable faster organic growth, and effectively get the Coala Heart Monitor out to even more patients in need.

Therefore, the factors above are expected to contribute to the growth of the cardiovascular devices market in Sweden. However, stringent regulatory systems and the high cost of devices and procedures might hamper the market's growth over the analysis period.

Sweden Cardiovascular Devices Industry Overview

The cardiovascular devices market in Sweden is highly competitive and consists of several major players. A few of the major players are currently dominating the market in terms of market share. Some key companies currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Occlutech, Scandinavian Real Heart AB, and Coala Life, among others.

Sweden Cardiovascular Devices Market Leaders

  1. Cardinal Health

  2. Medtronic

  3. Boston Scientific Corporation

  4. Biotronik

  5. Abbott Laboratories

  6. *Disclaimer: Major Players sorted in no particular order
Sweden Cardiovascular Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Sweden Cardiovascular Devices Market News

  • July 2023: Neko Health, a Swedish startup, received a funding of EUR 60 million (USD 65.8 million) in Series A financing. The Stockholm-based startup's medical scanning technology aims to collect extensive health data to aid doctors in catching diseases early, including cardiovascular diseases.
  • January 2022: The first successful pig heart transplant into a human patient was largely made possible by an organ preservation device from the Swedish company XVIVO. When surgeons at the University of Maryland School of Medicine successfully implanted a donor heart (pig heart) into a 57-year-old patient, the heart perfusion device of the XVIVO preserved the pig heart used in the surgery.

Sweden Cardiovascular Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Technological Advancements
    • 4.2.2 Increasing Burden of Cardiovascular Diseases
    • 4.2.3 Increased Preference of Minimally Invasive Procedures
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 High Cost of Instruments and Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Electrocardiogram (ECG)
    • 5.1.1.2 Remote Cardiac Monitoring
    • 5.1.1.3 Other Diagnostic and Monitoring Devices
    • 5.1.2 Therapeutic and Surgical Devices
    • 5.1.2.1 Cardiac Assist Devices
    • 5.1.2.2 Cardiac Rhythm Management Device
    • 5.1.2.3 Catheter
    • 5.1.2.4 Stent
    • 5.1.2.5 Other Therapeutic and Surgical Devices

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Biotronik
    • 6.1.4 Cardinal Health
    • 6.1.5 GE Healthcare
    • 6.1.6 W. L. Gore & Associates, Inc.
    • 6.1.7 Medtronic
    • 6.1.8 Siemens Healthineers AG
    • 6.1.9 Occlutech
    • 6.1.10 Scandinavian Real Heart AB
    • 6.1.11 Coala Life
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Sweden Cardiovascular Devices Industry Segmentation

As per the scope of the report, cardiovascular devices are used to diagnose and treat heart disease and related health problems. Also, cardiovascular devices regulate heart rhythm abnormalities and irregular heartbeat, two major examples of irregularities caused by the heart. The Swedish Cardiovascular Devices market is segmented by Device Type. By Device type, the market is segmented into Diagnostic and Monitoring Devices and Therapeutic and Surgical Devices. The report offers the value (in USD) for the above segments.

By Device Type Diagnostic and Monitoring Devices Electrocardiogram (ECG)
Remote Cardiac Monitoring
Other Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices Cardiac Assist Devices
Cardiac Rhythm Management Device
Catheter
Stent
Other Therapeutic and Surgical Devices
Need A Different Region or Segment?
Customize Now

Sweden Cardiovascular Devices Market Research FAQs

How big is the Sweden Cardiovascular Devices Market?

The Sweden Cardiovascular Devices Market size is expected to reach USD 0.34 billion in 2025 and grow at a CAGR of 4.20% to reach USD 0.42 billion by 2030.

What is the current Sweden Cardiovascular Devices Market size?

In 2025, the Sweden Cardiovascular Devices Market size is expected to reach USD 0.34 billion.

Who are the key players in Sweden Cardiovascular Devices Market?

Cardinal Health, Medtronic, Boston Scientific Corporation, Biotronik and Abbott Laboratories are the major companies operating in the Sweden Cardiovascular Devices Market.

What years does this Sweden Cardiovascular Devices Market cover, and what was the market size in 2024?

In 2024, the Sweden Cardiovascular Devices Market size was estimated at USD 0.33 billion. The report covers the Sweden Cardiovascular Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Sweden Cardiovascular Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Sweden Cardiovascular Devices Industry Report

Statistics for the 2025 Sweden Cardiovascular Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sweden Cardiovascular Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.